Perioperative Considerations of Novel Antidiabetic Agents in Heart Failure Patients Undergoing Cardiac Surgery

Diabetes mellitus (DM) is a major risk factor for cardiovascular disease, including heart failure (HF). A high proportion of DM patients eventually require cardiac surgery. While the traditional approach to DM therapy focuses on tight glucose control with insulin and oral hypoglycemic agents, novel...

Description complète

Détails bibliographiques

Auteurs principaux:	Ashley Wang, Savannah Bitzas, Dilsa Perez, Jonathon Schwartz, Saleem Zaidi, Jonathan Oster, Sergio D. Bergese
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2025-03-01
Collection:	Life
Sujets:	diabetes mellitus heart failure GLP-1 receptor agonist DPP-4 inhibitors SGLT2 inhibitors cardiac surgery
Accès en ligne:	https://www.mdpi.com/2075-1729/15/3/427
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!